Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiu-Mei Ma

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Radiation Research|March 12, 2014
Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomasJian Min Tang, Xiu Mei Ma, Yan Li Hou, et al.
Cell & Bioscience|July 7, 2021
Apatinib induces endoplasmic reticulum stress-mediated apoptosis and autophagy and potentiates cell sensitivity to paclitaxel via the IRE-1α-AKT-mTOR pathway in esophageal squamous cell carcinomaYu-Ming Wang, Xin Xu, Jian Tang, et al.
Clinical and Translational Radiation Oncology|August 2, 2024
The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective studyHui-Hui Hu, Xin Xu, Xiao-Yang Li, et al.
Phytotherapy Research : PTR|February 23, 2024
Effect of proanthocyanidins on blood lipids: A systematic review and meta-analysisPeng Wang, Xue Lian Liu, Zong Zhe Jiang, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 22, 2012
Mn2Au: body-centered-tetragonal bimetallic antiferromagnets grown by molecular beam epitaxyHan-Chun Wu, Zhi-Min Liao, R G Sumesh Sofin, et al.
Future Oncology (London, England)|November 8, 2023
Phase II multicenter trial: first-line immunochemotherapy with or without radiotherapy in metastatic esophageal squamous cell cancer (SCR-ESCC-01)Yue Li, Lin Lin, Jun Liu, et al.
International Journal of Biological Sciences|October 20, 2022
Circular RNA hsa_circ_0003823 promotes the Tumor Progression, Metastasis and Apatinib Resistance of Esophageal Squamous Cell Carcinoma by miR-607/CRISP3 AxisYu-Ming Wang, Qi-Wu Zhao, Zhi-Yong Sun, et al.
Cell Biology and Toxicology|March 2, 2022
Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetesXiu Mei Ma, Kang Geng, Betty Yuen-Kwan Law, et al.
Frontiers in Immunology|December 1, 2022
The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapyJin Zhou, Hai-Ping Lin, Xin Xu, et al.
Dose-Response : a Publication of International Hormesis Society|April 5, 2019
Research of Biological Dose Conversion Platform Based on a Modified Linear Quadratic ModelLi Yan Dai, Ren Hua Huang, Yun Zhou, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Radiation Research|March 12, 2014
Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomasJian Min Tang, Xiu Mei Ma, Yan Li Hou, et al.
Cell & Bioscience|July 7, 2021
Apatinib induces endoplasmic reticulum stress-mediated apoptosis and autophagy and potentiates cell sensitivity to paclitaxel via the IRE-1α-AKT-mTOR pathway in esophageal squamous cell carcinomaYu-Ming Wang, Xin Xu, Jian Tang, et al.
Clinical and Translational Radiation Oncology|August 2, 2024
The value of intervention with radiotherapy after first-line chemo-immunotherapy in locally advanced or metastatic esophageal squamous cell carcinoma: A multi-center retrospective studyHui-Hui Hu, Xin Xu, Xiao-Yang Li, et al.
Phytotherapy Research : PTR|February 23, 2024
Effect of proanthocyanidins on blood lipids: A systematic review and meta-analysisPeng Wang, Xue Lian Liu, Zong Zhe Jiang, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 22, 2012
Mn2Au: body-centered-tetragonal bimetallic antiferromagnets grown by molecular beam epitaxyHan-Chun Wu, Zhi-Min Liao, R G Sumesh Sofin, et al.
Future Oncology (London, England)|November 8, 2023
Phase II multicenter trial: first-line immunochemotherapy with or without radiotherapy in metastatic esophageal squamous cell cancer (SCR-ESCC-01)Yue Li, Lin Lin, Jun Liu, et al.
International Journal of Biological Sciences|October 20, 2022
Circular RNA hsa_circ_0003823 promotes the Tumor Progression, Metastasis and Apatinib Resistance of Esophageal Squamous Cell Carcinoma by miR-607/CRISP3 AxisYu-Ming Wang, Qi-Wu Zhao, Zhi-Yong Sun, et al.
Cell Biology and Toxicology|March 2, 2022
Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetesXiu Mei Ma, Kang Geng, Betty Yuen-Kwan Law, et al.
Frontiers in Immunology|December 1, 2022
The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapyJin Zhou, Hai-Ping Lin, Xin Xu, et al.
Dose-Response : a Publication of International Hormesis Society|April 5, 2019
Research of Biological Dose Conversion Platform Based on a Modified Linear Quadratic ModelLi Yan Dai, Ren Hua Huang, Yun Zhou, et al.
Pageof 4